GGrantIndex
Sort

78,016 grants matching breast cancer

Modeling the role and regulation of reactive stroma in breast ductal carcinoma microinvasions

$1,160,532
Katarzyna Anna Rejniak · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2025 · CA

Molecular Epidemiology Studies of Occupational and Environmental Exposures

$1,160,113
Nathaniel Rothman · Division Of Cancer Epidemiology And Genetics · ZIA · FY2014 · CA

Development of a potent and selective oral ENPP1 inhibitor for oncology

$1,160,011
Mohan Rao Kaadige · Stingray Therapeutics, Inc. · R44 · FY2022 · CA

Women's Health Initiative Sleep Hypoxia Effects on Resilience (WHISPER)

$1,159,882
Laura D. Baker · Wake Forest University Health Sciences · R01 · FY2020 · HL

Tumor-Stroma Interacions in the Tumor Microenvironment

$1,159,782
Richard O Hynes · Massachusetts Institute Of Technology · U54 · FY2007 · CA

NHGRI/DIR Genetic Counseling Training Program

$1,159,765
Colleen M Mc Bride · National Human Genome Research Institute · ZIE · FY2012 · HG

Tumor selective inhibition of the WNT pathway

$1,159,628
Lukas Edward Dow · Weill Medical Coll Of Cornell Univ · R01 · FY2025 · CA

Center for African American Urban Health

$1,159,493
John Mark Flack · Wayne State University · P50 · FY2006 · ES

TARGETED THERAPY FOR TRIPLE-NEGATIVE BREAST CANCER

$1,159,096
University Of Illinois · · FY2016 · Department of the Army

Novel Markers for Disease Outcome in Breast Cancer

$1,159,062
Stefan Ambs · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA

Occupational and Environmental Determinants of Cancer among Women and Minorities

$1,158,916
Wong Chow · Division Of Cancer Epidemiology And Genetics · Z01 · FY2008 · CA

ACCELERATING THE PRECLINICAL TESTING OF A PROMISING TARGETED THERAPEUTIC FOR TRIPLE-NEGATIVE BREAST CANCER

$1,158,742
Queensland University Of Technology · · FY2020 · Defense Health Agency

Center for Advanced Imaging Innovation and Research (CAI2R)

$1,158,678
Daniel K Sodickson · New York University School Of Medicine · P41 · FY2016 · EB

Early Life Exposures and Subsequent Cancer Risk

$1,158,639
Robert Hoover · Division Of Cancer Epidemiology And Genetics · ZIA · FY2009 · CA

Cellular Mechanisms Of Xenobiotic Transport

$1,158,379
David Miller · National Institute Of Environmental Health Sciences · ZIA · FY2009 · ES

GENE EXPRESSION IN CANCER BY MICROARRAY HYBRIDIZATION

$1,158,262
Stanford University · R01 · FY2002 · CA

TUMORS EFFECTS ON THE SKELETON

$1,158,090
University Of Texas Hlth Sci Ctr San Ant · P01 · FY2003 · CA

Proprietary drug to treat radiodermatitis

$1,157,986
Christian Young · Allander Biotechnologies, Inc. · R44 · FY2020 · AR

Molecular Mechanisms Regulating Mouse Mammary Gland and Human Breast Tumor Cells

$1,157,574
Gisela Sterneck · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA

Targeting intratumor heterogeneity in breast cancer

$1,157,073
Kornelia Polyak · Dana-Farber Cancer Inst · R35 · FY2018 · CA

Targeting intratumor heterogeneity in breast cancer

$1,157,073
Kornelia Polyak · Dana-Farber Cancer Inst · R35 · FY2021 · CA

Targeting intratumor heterogeneity in breast cancer

$1,157,072
Kornelia Polyak · Dana-Farber Cancer Inst · R35 · FY2020 · CA

Indiana University Melvin and Bren Simon Cancer Center Support Grant

$1,156,983
Patrick J Loehrer · Indiana University Indianapolis · P30 · FY2013 · CA

Coordinating Center for Population-based Research to Optimize Cancer Screening (PROSPR) (U24)

$1,156,938
Christopher I Li · Fred Hutchinson Cancer Research Center · U24 · FY2020 · CA

Roles of Chromatin-modifying Factors in Epigenetic Control of the Genome

$1,156,843
Shivinder S Grewal · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA